The risk or severity of adverse effects can be increased when duloxetine is combined with zotepine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with prilocaine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Axitinib.


The risk or severity of adverse effects can be increased when Toloxatone is combined with isoetharine.


The risk or severity of adverse effects can be increased when Tramadol is combined with clonidine.


The risk or severity of adverse effects can be increased when amobarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when amobarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when lorazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when benzocaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when trimeprazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when quazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when clorazepate is combined with clidinium.


The risk or severity of adverse effects can be increased when oxazepam is combined with halothane.


The risk or severity of adverse effects can be increased when Lacidipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when loxapine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with triprolidine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when oxazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when bupivacaine is combined with procaine.


The risk or severity of adverse effects can be increased when penbutolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when Salsalate is combined with epirizole.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when dipyridamole is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when thiopental is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when trimipramine is combined with selegiline.


The risk or severity of adverse effects can be increased when dopamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with butamben.


The risk or severity of adverse effects can be increased when Rotigotine is combined with nadolol.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with nimesulide.


The risk or severity of adverse effects can be increased when temazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when diazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when diazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Difenoxin.


The risk or severity of adverse effects can be increased when clorazepate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with amoxapine.


The risk or severity of adverse effects can be increased when meprobamate is combined with meclizine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with nortriptyline.


The risk or severity of adverse effects can be increased when indomethacin is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when clozapine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when losartan is combined with Riociguat.


The risk or severity of adverse effects can be increased when benazepril is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with AMMONIUM CHLORIDE.


The risk or severity of adverse effects can be increased when halothane is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when clonidine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when enflurane is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when codeine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when zopiclone is combined with dyclonine.


The risk or severity of adverse effects can be increased when topiramate is combined with clemastine.


The risk or severity of adverse effects can be increased when zopiclone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when morphine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when morphine is combined with gabapentin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with topiramate.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with baclofen.


The risk or severity of adverse effects can be increased when sulpiride is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when thioridazine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with cocaine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Telmisartan.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with nicardipine.


The risk or severity of adverse effects can be increased when Tramadol is combined with quetiapine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when trimipramine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with methyldopa.


The risk or severity of adverse effects can be increased when butamben is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when butamben is combined with Escitalopram.


The risk or severity of adverse effects can be increased when anagrelide is combined with Apixaban.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when tretinoin is combined with lisinopril.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when tretinoin is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when selegiline is combined with reserpine.


The risk or severity of adverse effects can be increased when pentazocine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when midazolam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when pimozide is combined with efavirenz.


The risk or severity of adverse effects can be increased when topotecan is combined with leflunomide.


The risk or severity of adverse effects can be increased when diltiazem is combined with Nebivolol.


The risk or severity of adverse effects can be increased when midazolam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with cilazapril.


The risk or severity of adverse effects can be increased when midazolam is combined with triazolam.


The risk or severity of adverse effects can be increased when atenolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with dantrolene.


The risk or severity of adverse effects can be increased when atenolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with ethotoin.


The risk or severity of adverse effects can be increased when lidocaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when celecoxib is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with prilocaine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with triamcinolone.


The risk or severity of adverse effects can be increased when chloroxine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when amisulpride is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nicergoline is combined with caffeine.


The risk or severity of adverse effects can be increased when nicergoline is combined with sildenafil.


The risk or severity of adverse effects can be increased when doxepin is combined with Vilanterol.


The risk or severity of adverse effects can be increased when nicergoline is combined with azithromycin.


The risk or severity of adverse effects can be increased when diltiazem is combined with penbutolol.


The risk or severity of adverse effects can be increased when meprobamate is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Normethadone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Eprosartan is combined with enalapril.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with diclofenac.


The risk or severity of adverse effects can be increased when thioridazine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when suprofen is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when tiagabine is combined with promethazine.


The risk or severity of adverse effects can be increased when tiagabine is combined with clonazepam.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with mafenide.


The risk or severity of adverse effects can be increased when biperiden is combined with Desloratadine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Asenapine.


The risk or severity of adverse effects can be increased when enalapril is combined with hydralazine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Butoconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with prednisone.


The risk or severity of adverse effects can be increased when butabarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with procaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with lisinopril.


The risk or severity of adverse effects can be increased when azelastine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with thiopental.


The risk or severity of adverse effects can be increased when amphotericin b is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with scopolamine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when clonidine is combined with enalapril.


The risk or severity of adverse effects can be increased when meperidine is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when gabapentin is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when butorphanol is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when halothane is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with oxaprozin.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when tropicamide is combined with Propiverine.


The risk or severity of adverse effects can be increased when sotalol is combined with floctafenine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with resveratrol.


The risk or severity of adverse effects can be increased when diflunisal is combined with suprofen.


The risk or severity of adverse effects can be increased when Milnacipran is combined with PHENPROCOUMON.


The risk or severity of adverse effects can be increased when atenolol is combined with indapamide.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with pentazocine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with triamcinolone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when risperidone is combined with amobarbital.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with moclobemide.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when amobarbital is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when floctafenine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when lidocaine is combined with etizolam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ethotoin is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Artemether is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Nepafenac.


The risk or severity of adverse effects can be increased when Telmisartan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when thiopental is combined with methocarbamol.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with nicotine.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with Cevimeline.


The risk or severity of adverse effects can be increased when scopolamine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiopental is combined with triprolidine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Olopatadine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with thiothixene.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ximelagatran.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with papaverine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with prazepam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with benazepril.


The risk or severity of adverse effects can be increased when Nepafenac is combined with prednisone.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Nepafenac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when chlormezanone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when tropicamide is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when alprazolam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with thiothixene.


The risk or severity of adverse effects can be increased when alprazolam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when tropicamide is combined with dicyclomine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when azelastine is combined with Apremilast.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Etidocaine.


The risk or severity of adverse effects can be increased when nicergoline is combined with oxybutynin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Etidocaine is combined with etizolam.


The risk or severity of adverse effects can be increased when lithium ion is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when cerulenin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Pipamperone is combined with butamben.


The risk or severity of adverse effects can be increased when hexetidine is combined with diltiazem.


The risk or severity of adverse effects can be increased when niflumic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when temazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when temazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when temazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when aspirin is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when methysergide is combined with prednisone.


The risk or severity of adverse effects can be increased when butorphanol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Etomidate is combined with triflupromazine.


The risk or severity of adverse effects can be increased when tretinoin is combined with nadolol.


The risk or severity of adverse effects can be increased when quinapril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when quinapril is combined with Droxicam.


The risk or severity of adverse effects can be increased when Melatonin is combined with tizanidine.


The risk or severity of adverse effects can be increased when citalopram is combined with zotepine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when cabergoline is combined with Asenapine.


The risk or severity of adverse effects can be increased when selegiline is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when antipyrine is combined with estrone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when quetiapine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when practolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when flurazepam is combined with isoflurane.


The risk or severity of adverse effects can be increased when Articaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Capsaicin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Delorazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when cilazapril is combined with alclofenac.


The risk or severity of adverse effects can be increased when sotalol is combined with acebutolol.


The risk or severity of adverse effects can be increased when ibuprofen is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with cilazapril.


The risk or severity of adverse effects can be increased when nimodipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when oxycodone is combined with Normethadone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with clonidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with vinblastine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with butalbital.


The risk or severity of adverse effects can be increased when meperidine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when alprazolam is combined with clonidine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with azelastine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with betamethasone.


The risk or severity of adverse effects can be increased when barnidipine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when felodipine is combined with irbesartan.


The risk or severity of adverse effects can be increased when morphine is combined with pimozide.


The risk or severity of adverse effects can be increased when rabeprazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Amrinone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when haloperidol is combined with oxazepam.


The risk or severity of adverse effects can be increased when midazolam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Arotinolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when methysergide is combined with Capsaicin.


The risk or severity of adverse effects can be increased when gabapentin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when clidinium is combined with maprotiline.


The risk or severity of adverse effects can be increased when zotepine is combined with tiagabine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when Posaconazole is combined with vinblastine.


The risk or severity of adverse effects can be increased when oxazepam is combined with estazolam.


The risk or severity of adverse effects can be increased when zotepine is combined with zonisamide.


The risk or severity of adverse effects can be increased when nortriptyline is combined with citalopram.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Rotigotine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when efavirenz is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Droxicam is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when thiothixene is combined with HEROIN.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when floctafenine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when losartan is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nilvadipine.


The risk or severity of adverse effects can be increased when difluprednate is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when Spirapril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when losartan is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with diflunisal.


The risk or severity of adverse effects can be increased when difluprednate is combined with memantine.


The risk or severity of adverse effects can be increased when morphine is combined with thiopental.


The risk or severity of adverse effects can be increased when benztropine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when HEROIN is combined with Articaine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with clemastine.


The risk or severity of adverse effects can be increased when nadolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when moclobemide is combined with amisulpride.


The risk or severity of adverse effects can be increased when amphotericin b is combined with diltiazem.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when proparacaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when rasagiline is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with bumetanide.


The risk or severity of adverse effects can be increased when prazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when salicylic acid is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Treprostinil is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when zaleplon is combined with halothane.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with trimipramine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when imipramine is combined with naratriptan.


The risk or severity of adverse effects can be increased when dexamethasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with haloperidol.


The risk or severity of adverse effects can be increased when procaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when procaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when tiapride is combined with clidinium.


The risk or severity of adverse effects can be increased when hydromorphone is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when zaleplon is combined with thiamylal.


The risk or severity of adverse effects can be increased when procaine is combined with meclizine.


The risk or severity of adverse effects can be increased when propantheline is combined with methadone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when imipramine is combined with losartan.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when morphine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when thioridazine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with HEROIN.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Icatibant.


The risk or severity of adverse effects can be increased when pentostatin is combined with leflunomide.


The risk or severity of adverse effects can be increased when meprobamate is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when meprobamate is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when meprobamate is combined with duloxetine.


The risk or severity of adverse effects can be increased when papaverine is combined with captopril.


The risk or severity of adverse effects can be increased when bepridil is combined with timolol.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when HEROIN is combined with baclofen.


The risk or severity of adverse effects can be increased when Normethadone is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Normethadone is combined with polythiazide.


The risk or severity of adverse effects can be increased when Normethadone is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when haloperidol is combined with brotizolam.


The risk or severity of adverse effects can be increased when Olsalazine is combined with budesonide.


The risk or severity of adverse effects can be increased when thiothixene is combined with thiopental.


The risk or severity of adverse effects can be increased when Nabilone is combined with penbutolol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with clonidine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Spirapril.


The risk or severity of adverse effects can be increased when indinavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Tramadol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when indinavir is combined with toremifene.


The risk or severity of adverse effects can be increased when primidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when oxprenolol is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when HEROIN is combined with prazepam.


The risk or severity of adverse effects can be increased when Fosamprenavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when HEROIN is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Etidocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when etizolam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when morphine is combined with halothane.


The risk or severity of adverse effects can be increased when methoxamine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with reserpine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when imipramine is combined with isoetharine.


The risk or severity of adverse effects can be increased when Butethal is combined with ethotoin.


The risk or severity of adverse effects can be increased when trazodone is combined with promethazine.


The risk or severity of adverse effects can be increased when trazodone is combined with clonazepam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Dronedarone.


The risk or severity of adverse effects can be increased when trazodone is combined with Melatonin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with loratadine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when trazodone is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Bretylium.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when oxycodone is combined with thiamylal.


The risk or severity of adverse effects can be increased when Vilazodone is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Vilazodone is combined with naratriptan.


The risk or severity of adverse effects can be increased when pramipexole is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when desipramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when acemetacin is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when dibucaine is combined with halothane.


The risk or severity of adverse effects can be increased when amobarbital is combined with Flibanserin.


The risk or severity of adverse effects can be increased when dibucaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with nimesulide.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Olopatadine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Telmisartan is combined with chloroquine.


The risk or severity of adverse effects can be increased when equilin is combined with enoxacin.


The risk or severity of adverse effects can be increased when Telmisartan is combined with sulindac.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bretylium.


The risk or severity of adverse effects can be increased when amifostine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when enalapril is combined with carvedilol.


The risk or severity of adverse effects can be increased when timolol is combined with trandolapril.


The risk or severity of adverse effects can be increased when zaleplon is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when suprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when lorazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with aspirin.


The risk or severity of adverse effects can be increased when aspirin is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when lorazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when lorazepam is combined with isoflurane.


The risk or severity of adverse effects can be increased when Nabilone is combined with nisoldipine.


The risk or severity of adverse effects can be increased when amoxapine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when amoxapine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when propranolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when selegiline is combined with zotepine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when apomorphine is combined with clonidine.


The risk or severity of adverse effects can be increased when selegiline is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with thiothixene.


The risk or severity of adverse effects can be increased when pentazocine is combined with ketamine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with pargyline.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when flunisolide is combined with enoxacin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with niflumic acid.


The risk or severity of adverse effects can be increased when tropicamide is combined with Metixene.


The risk or severity of adverse effects can be increased when docetaxel is combined with Midostaurin.


The risk or severity of adverse effects can be increased when floctafenine is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when chloroquine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with hydralazine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Retigabine.


The risk or severity of adverse effects can be increased when Alogliptin is combined with ramipril.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with zotepine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Clevidipine.


The risk or severity of adverse effects can be increased when olanzapine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when olanzapine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with thiopental.


The risk or severity of adverse effects can be increased when diltiazem is combined with tizanidine.


The risk or severity of adverse effects can be increased when diltiazem is combined with furosemide.


The risk or severity of adverse effects can be increased when itraconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Articaine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when acemetacin is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with felodipine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with alclometasone.


The risk or severity of adverse effects can be increased when dibucaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when dibucaine is combined with clemastine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with amobarbital.


The risk or severity of adverse effects can be increased when floctafenine is combined with celecoxib.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Mometasone.


The risk or severity of adverse effects can be increased when triazolam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when bromazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when trimetrexate is combined with isradipine.


The risk or severity of adverse effects can be increased when ritodrine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Eprosartan.


The risk or severity of adverse effects can be increased when haloperidol is combined with glutethimide.


The risk or severity of adverse effects can be increased when Desloratadine is combined with clomipramine.


The risk or severity of adverse effects can be increased when ramipril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when promazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when metoprolol is combined with atenolol.


The risk or severity of adverse effects can be increased when felbamate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Pentolinium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when diflunisal is combined with DESONIDE.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when carisoprodol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ketoprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Naftifine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Alogliptin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Olmesartan is combined with spironolactone.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when tropicamide is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when loxapine is combined with protriptyline.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with DESONIDE.


The risk or severity of adverse effects can be increased when triprolidine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when apraclonidine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with thiothixene.


The risk or severity of adverse effects can be increased when Apremilast is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with dantrolene.


The risk or severity of adverse effects can be increased when sulindac is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when oxymorphone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when gabapentin is combined with Melatonin.


The risk or severity of adverse effects can be increased when temazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with meclizine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with doxepin.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Riociguat.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with duloxetine.


The risk or severity of adverse effects can be increased when baclofen is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Droxicam is combined with prednisone.


The risk or severity of adverse effects can be increased when Talniflumate is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Droxicam is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Paliperidone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when oxazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when amoxapine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when propoxyphene is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when codeine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when losartan is combined with penbutolol.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with doxepin.


The risk or severity of adverse effects can be increased when codeine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when docetaxel is combined with quinacrine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with estrone.


The risk or severity of adverse effects can be increased when clidinium is combined with dantrolene.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Imatinib is combined with oxycodone.


The risk or severity of adverse effects can be increased when lorazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when indapamide is combined with carvedilol.


The risk or severity of adverse effects can be increased when papaverine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with quinapril.


The risk or severity of adverse effects can be increased when clomipramine is combined with isoetharine.


The risk or severity of adverse effects can be increased when benazepril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with bumetanide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Phenelzine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with cetirizine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with tiapride.


The risk or severity of adverse effects can be increased when tretinoin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when itraconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with protriptyline.


The risk or severity of adverse effects can be increased when chloroquine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when alclometasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when propantheline is combined with HEROIN.


The risk or severity of adverse effects can be increased when scopolamine is combined with pancuronium.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Butethal.


The risk or severity of adverse effects can be increased when Lacidipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when procyclidine is combined with Propiverine.


The risk or severity of adverse effects can be increased when cilazapril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when procaine is combined with sertraline.


The risk or severity of adverse effects can be increased when butabarbital is combined with clonidine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with protriptyline.


The risk or severity of adverse effects can be increased when tizanidine is combined with methazolamide.


The risk or severity of adverse effects can be increased when tizanidine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when amisulpride is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when triazolam is combined with clidinium.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with propantheline.


The risk or severity of adverse effects can be increased when fludiazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with tizanidine.


The risk or severity of adverse effects can be increased when meclizine is combined with dantrolene.


The risk or severity of adverse effects can be increased when isoflurane is combined with metoprolol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with rasagiline.


The risk or severity of adverse effects can be increased when apomorphine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when clozapine is combined with enflurane.


The risk or severity of adverse effects can be increased when tolmetin is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with amisulpride.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when methyldopa is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Butethal is combined with Etidocaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when secobarbital is combined with flurazepam.


The risk or severity of adverse effects can be increased when Talniflumate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when olanzapine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when olanzapine is combined with zotepine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with methyldopa.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Tixocortol is combined with memantine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with mepivacaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when labetalol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when clomipramine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Camazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with clorazepate.


The risk or severity of adverse effects can be increased when phenobarbital is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when clonidine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when glipizide is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Retigabine.


The risk or severity of adverse effects can be increased when captopril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with fenbufen.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when glutethimide is combined with nefazodone.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when ropinirole is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Eplerenone is combined with papaverine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Metipranolol.


The risk or severity of adverse effects can be increased when glutethimide is combined with doxepin.


The risk or severity of adverse effects can be increased when argatroban is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when ropinirole is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Tramadol is combined with flunarizine.


The risk or severity of adverse effects can be increased when nicergoline is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with duloxetine.


The risk or severity of adverse effects can be increased when nicergoline is combined with daunorubicin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when Remoxipride is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with methazolamide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when halothane is combined with MELPERONE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with trimipramine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when perphenazine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when oxycodone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when citalopram is combined with cabergoline.


The risk or severity of adverse effects can be increased when barnidipine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with carvedilol.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Bambuterol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with prazosin.


The risk or severity of adverse effects can be increased when amobarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Mometasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when amobarbital is combined with sulpiride.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with terbutaline.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when selegiline is combined with metaproterenol.


The risk or severity of adverse effects can be increased when tirofiban is combined with aspirin.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with tubocurarine.


The risk or severity of adverse effects can be increased when citalopram is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when loxapine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when flurazepam is combined with gabapentin.


The risk or severity of adverse effects can be increased when ketorolac is combined with amcinonide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with oxymorphone.


The risk or severity of adverse effects can be increased when tolterodine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when ketorolac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when nalbuphine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when bromazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when reserpine is combined with clidinium.


The risk or severity of adverse effects can be increased when bromazepam is combined with procaine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when propofol is combined with Butethal.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when propofol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when propofol is combined with penbutolol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with clidinium.


The risk or severity of adverse effects can be increased when quinapril is combined with nadolol.


The risk or severity of adverse effects can be increased when Fospropofol is combined with baclofen.


The risk or severity of adverse effects can be increased when halothane is combined with efavirenz.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with felodipine.


The risk or severity of adverse effects can be increased when dapsone is combined with phenytoin.


The risk or severity of adverse effects can be increased when Apremilast is combined with alclometasone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with amoxapine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when labetalol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with trazodone.


The risk or severity of adverse effects can be increased when Etomidate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Ramelteon is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when loxapine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Retigabine.


The risk or severity of adverse effects can be increased when leflunomide is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when buprenorphine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when flurazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when Melatonin is combined with tiagabine.


The risk or severity of adverse effects can be increased when enflurane is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Pazopanib.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when epinastine is combined with aspirin.


The risk or severity of adverse effects can be increased when thiamylal is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when carbamazepine is combined with brotizolam.


The risk or severity of adverse effects can be increased when ROLITETRACYCLINE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when venlafaxine is combined with doxepin.


The risk or severity of adverse effects can be increased when isradipine is combined with terazosin.


The risk or severity of adverse effects can be increased when barnidipine is combined with imipramine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Naftifine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with topiramate.


The risk or severity of adverse effects can be increased when Torasemide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when promazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when pentazocine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when dyclonine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with triazolam.


The risk or severity of adverse effects can be increased when timolol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when alprazolam is combined with amobarbital.


The risk or severity of adverse effects can be increased when methadone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when temazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when quazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when pentazocine is combined with benzocaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with phentolamine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Bortezomib.


The risk or severity of adverse effects can be increased when ritodrine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when barnidipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when ritodrine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with budesonide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when trimipramine is combined with isoetharine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when propranolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when cabergoline is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when benazepril is combined with carvedilol.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with memantine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with furosemide.


The risk or severity of adverse effects can be increased when oxazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when clorazepate is combined with Articaine.


The risk or severity of adverse effects can be increased when oxazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when oxazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Lofexidine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when carbamazepine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when carbamazepine is combined with triprolidine.


The risk or severity of adverse effects can be increased when clorazepate is combined with dibucaine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when reserpine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with brimonidine.


The risk or severity of adverse effects can be increased when cabergoline is combined with norfloxacin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with celecoxib.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with carvedilol.


The risk or severity of adverse effects can be increased when cabergoline is combined with nitrendipine.


The risk or severity of adverse effects can be increased when butamben is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Agomelatine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Agomelatine is combined with promethazine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with resveratrol.


The risk or severity of adverse effects can be increased when Tramadol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when topiramate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Tramadol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with fosinopril.


The risk or severity of adverse effects can be increased when trazodone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when topiramate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with lithium ion.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when rasagiline is combined with tiapride.


The risk or severity of adverse effects can be increased when hydromorphone is combined with zonisamide.


The risk or severity of adverse effects can be increased when baclofen is combined with vigabatrin.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Halazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when baclofen is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when xylometazoline is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with sotalol.


The risk or severity of adverse effects can be increased when maprotiline is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with flunarizine.


The risk or severity of adverse effects can be increased when Butethal is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when trimipramine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Nabilone.


The risk or severity of adverse effects can be increased when trimipramine is combined with moclobemide.


The risk or severity of adverse effects can be increased when Spirapril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when nicergoline is combined with norfloxacin.


The risk or severity of adverse effects can be increased when zaleplon is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when nicergoline is combined with nitrendipine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when linezolid is combined with promazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when reserpine is combined with amoxapine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with meclizine.


The risk or severity of adverse effects can be increased when meprobamate is combined with thioridazine.


The risk or severity of adverse effects can be increased when enalapril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ketorolac.


The risk or severity of adverse effects can be increased when Sacubitril is combined with acebutolol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with nabumetone.


The risk or severity of adverse effects can be increased when enalapril is combined with nabumetone.


The risk or severity of adverse effects can be increased when ibuprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when pramipexole is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when enalapril is combined with ketorolac.


The risk or severity of adverse effects can be increased when chlormezanone is combined with venlafaxine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with sumatriptan.


The risk or severity of adverse effects can be increased when lithium ion is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when temazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when metaproterenol is combined with Ephedrine.


The risk or severity of adverse effects can be increased when temazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sildenafil.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with ouabain.


The risk or severity of adverse effects can be increased when oxprenolol is combined with clomipramine.


The risk or severity of adverse effects can be increased when thiothixene is combined with phenytoin.


The risk or severity of adverse effects can be increased when meprobamate is combined with Fospropofol.


The risk or severity of adverse effects can be increased when methazolamide is combined with papaverine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Normethadone.


The risk or severity of adverse effects can be increased when mesalamine is combined with loteprednol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Etidocaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Crizotinib.


The risk or severity of adverse effects can be increased when meprobamate is combined with levodopa.


The risk or severity of adverse effects can be increased when Etidocaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when loxapine is combined with thioridazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when clotrimazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when olanzapine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Clevidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with clomipramine.


The risk or severity of adverse effects can be increased when zopiclone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Etomidate is combined with Perospirone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with imipramine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with felbamate.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with resveratrol.


The risk or severity of adverse effects can be increased when benzocaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Eprosartan.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methadone is combined with meprobamate.


The risk or severity of adverse effects can be increased when spironolactone is combined with Riociguat.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with diflorasone.


The risk or severity of adverse effects can be increased when amobarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when pentazocine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when nabumetone is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when nabumetone is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Efonidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Lacidipine.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Benidipine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when minoxidil is combined with Riociguat.


The risk or severity of adverse effects can be increased when benzoic acid is combined with cilnidipine.


The risk or severity of adverse effects can be increased when sulfacetamide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with manidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with triazolam.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with mefloquine.


The risk or severity of adverse effects can be increased when celecoxib is combined with dexamethasone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when oxprenolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when ERYTHRITYL TETRANITRATE is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with doxazosin.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when prilocaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when tioconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with labetalol.


The risk or severity of adverse effects can be increased when gabapentin is combined with quetiapine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with tetracaine.


The risk or severity of adverse effects can be increased when sulpiride is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Vinflunine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with methazolamide.


The risk or severity of adverse effects can be increased when methadone is combined with thiopental.


The risk or severity of adverse effects can be increased when docetaxel is combined with bicalutamide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with duloxetine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with fluoxetine.


The risk or severity of adverse effects can be increased when nifedipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when butabarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when halothane is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Apremilast is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Apremilast is combined with paramethasone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when alclometasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when diazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with clomipramine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when reserpine is combined with butabarbital.


The risk or severity of adverse effects can be increased when reserpine is combined with temazepam.


The risk or severity of adverse effects can be increased when reserpine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with efavirenz.


The risk or severity of adverse effects can be increased when mesalamine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when resveratrol is combined with Halobetasol.


The risk or severity of adverse effects can be increased when resveratrol is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Salsalate.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when topiramate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with salicylamide.


The risk or severity of adverse effects can be increased when antipyrine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when antipyrine is combined with fenbufen.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Agomelatine is combined with flunarizine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with fluoxetine.